Bausch Health Companies Inc. Shareholders' Equity
Bausch Health Companies Inc. (BHC) had Shareholders' Equity of -$1.77 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.77B.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$2.06B.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$554.00M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$565.00M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$1.77B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$2.06B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | -$554.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | -$565.00M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | -$764.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | -$1.18B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | -$1.28B 10-K · filed 2026-02-19 | |
| 2024-09-30 | -$1.17B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$1.18B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$1.11B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | -$1.02B 10-K · filed 2025-02-20 | |
| 2023-09-30 | -$1.18B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$663.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$800.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$692.00M 10-K · filed 2024-02-22 | |
| 2022-09-30 | -$525.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$693.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$216.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$106.00M 10-K · filed 2023-02-23 | |
| 2021-09-30 | -$204.00M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | -$687.00M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$197.00M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $535.00M 8-K · filed 2022-05-11 | |
| 2020-09-30 | $587.00M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $474.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $719.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.06B 8-K · filed 2021-05-04 | |
| 2019-09-30 | $2.48B 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $2.60B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.69B 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $2.73B 10-K · filed 2020-02-19 | |
| 2018-09-30 | $3.15B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $3.47B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.54B 10-Q · filed 2019-05-06 | $4.42B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.85B 10-K · filed 2019-02-20 | |
| 2017-09-30 | $5.33B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $3.93B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $3.89B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.15B 8-K · filed 2018-08-10 | |
| 2016-09-30 | $4.17B 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.30B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.66B 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $5.91B 10-K · filed 2017-03-01 | $5.91B 10-K · filed 2016-04-29 |
| 2015-09-30 | $6.34B 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $6.44B 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $6.45B 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $5.28B 10-K · filed 2016-04-29 | $5.31B 10-K · filed 2015-02-25 |
| 2014-09-30 | $5.12B 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $5.26B 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $5.09B 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $5.12B 10-K · filed 2015-02-25 | $5.12B 10-K · filed 2014-02-28 |
| 2013-09-30 | $4.95B 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $5.70B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $3.59B 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $3.72B 10-K · filed 2015-02-25 | $3.72B 10-K · filed 2013-02-28 |
| 2012-09-30 | $3.79B 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $3.70B 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $4.08B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $3.93B 10-K · filed 2015-02-25 | $4.01B 10-K · filed 2012-02-29 |
| 2011-09-30 | $4.01B 10-Q · filed 2011-11-04 | |
| 2010-12-31 | $4.91B 10-K · filed 2014-02-28 | |
| 2009-12-31 | $1.35B 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |